SFRP1 protein acts as a WNT antagonist, and thus a tumor suppressor, by inhibiting the activation of the WNT pathway, which when activated can influence cell proliferation, survival and invasion by the canonical/β-catenin pathway and cell adhesion, migration and cytoskeletal reorganization by the non-canonical pathway [42]. The gene discussed is SFRP1; the disease is neoplasm.